In mammography, low-dose X-rays are used for the examination of the human breast. During the procedure, each breast is pressed between two plates and an X-ray image is made. These images are called mammograms and are used to detect early signs of breast cancer such as a dense mass or clusters of calcium. Mammography equipment is used as a diagnostic and screening tool. The three kinds of mammograms available are 3D mammography (tomosynthesis), 2D mammography, and screen-film (or analog) mammography.
MIR analysts forecast the global mammography market to grow at a CAGR of 10.08% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global mammography market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of mammography equipment.
The market is divided into the following segments based on geography:
MIR report, Global Mammography Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
• GE Healthcare
• Philips Healthcare
• Siemens Healthcare
• FUJIFILM Holdings
Other prominent vendors
• Carestream Health
• Internazionale Medico Scientifica
• Planmed Oy
• Toshiba Medical Systems
• Trivitron Healthcare
• Rising incidence of breast cancer
• For a full, detailed list, view our report
• High cost of mammography equipment
• For a full, detailed list, view our report
• New product launches/approvals coupled with R&D activities
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
MIR recognizes the following companies as the key players in the global mammography market: Hologic, GE Healthcare, Philips Healthcare, Siemens Healthcare, and FUJIFILM Holdings.
Other Prominent Vendors in the market are: Agfa-Gevaert, Carestream Health, Internazionale Medico Scientifica, Metaltronica, PerkinElmer, Planmed Oy, Shimadzu, Toshiba Medical Systems, and Trivitron Healthcare.
Commenting on the report, an analyst from MIR team said: “The latest trend gaining momentum in the market is new product launches/approvals coupled with R&D activities. Vendors are increasingly focusing on the development and launch of new mammography equipment. New product launches coupled with R&D activities will enable the vendors to sustain in the market and to enhance their growth. Vendors are actively involved in launching innovative devices for improving the comfortability and accuracy of the mammographic images.”
According to the report, one of the major drivers for this market is rising incidence of breast cancer. Breast cancer is a common type of cancer and is one of the main causes of the high mortality in women. There is a significant rise in the number of the incidence rate from past 25 years, particularly among postmenopausal women.
Further, the report states that one of the major factors hindering the growth of this market is high cost of mammography equipment. Medical imaging procedures such as digital mammography are the most revenue generating areas for any healthcare facility. However, digital mammography equipment is expensive and classified as capital equipment that requires budget allocation and high maintenance, which makes this equipment costly. Although there is a rising shift toward the digital mammography over the conventional mammography among the end-users, the high cost of equipment will have an adverse impact on the market growth.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
PART 01: Executive summary
PART 02: Scope of the report
PART 03: research methodology
PART 04: Market landscape
â¢ Market overview
â¢ Five forces analysis
PART 05: Market segmentation by product
â¢ Market overview
â¢ 2D mammography
â¢ 3D mammography
â¢ Analog (screen-film) mammography
PART 06: Market segmentation by end-user
â¢ Diagnostic centers
PART 07: Geographical segmentation
â¢ Mammography market in Americas
â¢ Mammography market in EMEA
â¢ Mammography market in APAC
PART 08: Decision framework
PART 09: Drivers and challenges
â¢ Market drivers
â¢ Market challenges
PART 10: Market trends
â¢ New product launches/approvals coupled with R&D activities
â¢ Advancements in mammographic equipment through CAD technology
â¢ Growing demand for CEM
PART 11: Vendor landscape
â¢ Competitive scenario
â¢ Geographical presence of the key vendors
â¢ Key news
PART 12: Key vendor analysis
â¢ GE Healthcare
â¢ Philips Healthcare
â¢ Siemens Healthcare
â¢ FUJIFILM Holdings
â¢ Other prominent vendors
PART 13: Appendix
â¢ List of abbreviations
List of Exhibits
Exhibit 01: Market overview: Global mammography market
Exhibit 02: Global mammography market 2016-2021 ($ millions)
Exhibit 03: Opportunity analysis: Global mammography market
Exhibit 04: Five forces analysis
Exhibit 05: Global mammography market segmentation by product type
Exhibit 06: Evolution of mammography systems
Exhibit 07: Global mammography market segmentation by product type 2016
Exhibit 08: Global mammography market segmentation by product type 2016 and 2021 (%)
Exhibit 09: Segmentation of global mammography market by product type 2016-2021 ($ millions)
Exhibit 10: Segmentation of global mammography market by product type 2016-2021 (%)
Exhibit 11: Global 2D mammography market 2016-2021 ($ millions)
Exhibit 12: Global 3D mammography market 2016-2021 ($ millions)
Exhibit 13: Global analog mammography market 2016-2021 ($ millions)
Exhibit 14: Global mammography market segmentation by end-users 2016
Exhibit 15: Global mammography market segmentation by geography 2016 and 2021 ($ millions)
Exhibit 16: Global mammography market segmentation by geography 2016 and 2021 (%)
Exhibit 17: Country-wise yearly prevalence of breast cancer on an average 2014
Exhibit 18: Region-wise yearly breast cancer incidences versus mortality comparison 2014
Exhibit 19: Global mammography market: Country-wise revenue and growth analysis
Exhibit 20: Susan G. Komen supported active health grants for women in LATAM
Exhibit 21: Market overview: Americas
Exhibit 22: Mammography market in Americas 2016-2021 ($ millions)
Exhibit 23: Market overview: EMEA
Exhibit 24: Mammography market in EMEA 2016-2021 ($ millions)
Exhibit 25: Market overview: APAC
Exhibit 26: Mammography market in APAC 2016-2021 ($ millions)
Exhibit 27: Global mammography market by geography 2016-2021 ($ millions)
Exhibit 28: Global mammography market by geography 2016-2021 (%)
Exhibit 29: Incidence of breast cancer 2010-2016
Exhibit 30: Government initiatives for breast cancer screening in some countries
Exhibit 31: Major vendors' refurbished equipment cost
Exhibit 32: New product launches in 2016
Exhibit 33: Competitive structure analysis of global mammography market 2016
Exhibit 34: Market penetration of various mammography system manufacturers globally in 2016
Exhibit 35: Leading vendors ranking 2016
Exhibit 36: Share of vendors in global mammography market 2016
Exhibit 37: Regional analysis of key vendors
Exhibit 38: Hologic: Key highlights
Exhibit 39: Hologic: Strength assessment
Exhibit 40: Hologic: Strategy assessment
Exhibit 41: Hologic: Opportunity assessment
Exhibit 42: GE Healthcare: Key highlights
Exhibit 43: GE Healthcare: Strength assessment
Exhibit 44: GE Healthcare: Strategy assessment
Exhibit 45: GE Healthcare: Opportunity assessment
Exhibit 46: Philips Healthcare: Key highlights
Exhibit 47: Philips Healthcare: Strength assessment
Exhibit 48: Philips Healthcare: Strategy assessment
Exhibit 49: Philips Healthcare: Opportunity assessment
Exhibit 50: Siemens Healthcare: Key highlights
Exhibit 51: Siemens Healthcare: Strength assessment
Exhibit 52: Siemens Healthcare: Strategy assessment
Exhibit 53: Siemens Healthcare: Opportunity assessment
Exhibit 54: FUJIFILM Holdings: Key highlights
Exhibit 55: FUJIFILM Holdings: Strength assessment
Exhibit 56: FUJIFILM Holdings: Strategy assessment
Exhibit 57: FUJIFILM Holdings: Opportunity assessment
Companies Mentioned are -Hologic, GE Healthcare, Philips Healthcare, Siemens Healthcare, FUJIFILM Holdings, Agfa-Gevaert, Carestream Health, Internazionale Medico Scientifica, Metaltronica, PerkinElmer, Planmed Oy, Shimadzu, Toshiba Medical Systems, and Trivitron Healthcare.
Research Methodology- Research methodology is based on extensive primary and secondary research. Primary research includes in-depth interviews with industry experts, vendors, resellers and customers. Secondary research includes Technavio Platform, industry publications, company reports, news articles, analyst reports, trade associations and the data published by Government agencies.
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.